DermNet provides Google Translate, a free machine translation service. Note that this may not provide an exact translation in all languages
Author: Hon A/Prof Amanda Oakley, Dermatologist, Hamilton, New Zealand, 2012. Updated September 2015.
Neutrophilic dermatosis of the hands is considered a localised variant of acute febrile neutrophilic dermatosis or Sweet syndrome, in which bluish or grey abscess-like nodules and blisters arise on the hands. They most often occur on the back of the hands, thumb or fingers but sometimes arise on the palmar surface. These nodules may ulcerate.
Neutrophilic dermatosis of the hands was previously known as ‘pustular vasculitis’ of the hands, because inflamed blood vessels are seen on biopsy as well as an infiltration of neutrophil white cells.
Neutrophilic dermatoses are skin conditions characterised by dense infiltration of inflammatory cells (neutrophils) in the affected tissue. They arise in reaction to some underlying systemic illness. A neutrophilic dermatosis may be seen in isolation or more than one type may occur in the same individual.
Neutrophilic dermatoses often arise at the site of injury such as a needle prick, biopsy or insect bite. This reaction to injury is known as Koebner phenomenon or isomorphic response. Pathergy is the production of a papule or pustule at the site of a needle prick.
Neutrophilic dermatoses include:
Neutrophilic dermatosis of the hands develops in reaction to some internal condition. It is mostly seen in elderly patients. It is associated with haematological problems in about half of patients, especially myelodysplasia and leukaemia. Other cases have been reported in association with many other underlying disorders including those listed below.
In some people with neutrophilic dermatosis of the hands, no underlying condition is found.
Neutrophilic dermatosis of the hands is often diagnosed clinically. A skin biopsy is usually performed to confirm it.
Diagnostic histopathological features of a dense infiltrate of polynuclear neutrophil inflammatory cells (neutrophils) without true vasculitis.
Blood tests in patients with neutrophilic dermatosis of the hands may reveal:
Neutrophilic dermatosis of the hands may be the presenting sign of a serious blood condition. A full blood count may reveal raised or reduced numbers of red cells, white cells and/or platelets. Further investigation may require bone marrow examination.
The lesions resolve eventually without leaving a mark or scar, with or without treatment.
Generally there is a single episode of neutrophilic dermatosis of the hands, but some patients may develop recurrent episodes. This is more likely in patients who have underlying myelodysplasia or cancer.
Treatment of neutrophilic dermatosis of the hands usually results in rapid improvement in symptoms. Usually, ultrapotent topical corticosteroids and/or systemic corticosteroids, such as predniso(lo)ne, are prescribed in a dose of 30-40 mg daily. Within a few days the fever, skin lesions and other symptoms clear up. However, lower doses of steroids are often required for several weeks to months to prevent relapse.
Several other medications may be tried when steroids are ineffective or contraindicated. These include:
In some cases, neutrophilic dermatosis of the hands is very resistant to treatment.
See the DermNet NZ bookstore
© 2021 DermNet New Zealand Trust.
DermNet NZ does not provide an online consultation service. If you have any concerns with your skin or its treatment, see a dermatologist for advice.